Add BrightSurf on Google Email

New paper outlines roadmap for next generation of brain-computer interfaces designed to treat cognitive disorders

A new review proposes a roadmap for developing cognitive brain-computer interfaces to treat cognitive disorders, integrating BCI research and clinical neuromodulation. The emerging field aims to detect dysfunctional brain states and respond with adaptive neurostimulation.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalTrends in Cognitive Sciences·TypeCommentary/editorial·DateJul 20, 2026

Dementia risk may also be reduced through diet

A review of hundreds of studies suggests that polyphenol-rich foods like berries, tea, and olive oil may support healthy brain aging by reducing inflammation and promoting nerve cell function. While no single food can prevent Alzheimer's disease, a balanced diet rich in plant-based foods may help preserve cognitive function over time.

SourceSemmelweis University·JournalNutrients·DateJul 14, 2026

Peer-reviewed study confirms CVI range is a valid, reliable tool for assessing cortical visual impairment in children

A new study published in Ophthalmology Science has confirmed that The CVI Range Assessment is a valid and reliable instrument for evaluating functional vision in children with Cortical Visual Impairment (CVI). This finding provides evidence that the widely used assessment meets rigorous clinical and psychometric standards, offering a s...

SourceThe Children’s Home of Pittsburgh·JournalOphthalmology Science·DateJul 13, 2026

Brain network disorders study reveals astrocyte shifts linked to mood disorders

A recent study reveals that astrocyte subtype dynamics play a crucial role in regulating mental health, particularly in mood disorders such as depression and anxiety. The review highlights how inflammatory signaling, metabolic imbalance, and ion channel dysfunction contribute to disease progression.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateJul 9, 2026

EV-SELEX: A novel platform for rapid G protein-coupled receptor drug discovery

A new aptamer selection strategy termed extracellular vesicle (EV)-SELEX has been developed to rapidly identify highly specific DNA aptamers targeting G protein-coupled receptors. The EV-SELEX platform exploits a natural cellular process to minimize interference and efficiently select biologically relevant receptor conformations.

SourceUniversity of Toyama·JournalCommunications Biology·TypeExperimental study·DateJul 7, 2026

Study finds little to no cortical lewy pathology in living Parkinson’s disease patients undergoing deep brain stimulation

Researchers found that patients with Parkinson's disease showing little to no Lewy bodies despite long-standing, clinically advanced disease. The study provides new insight into the relationship between clinical symptoms and neuropathological progression.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·Journalnpj Parkinson s Disease·TypeObservational study·DateJul 1, 2026

First-of-its-kind cell therapy clinical trial led by Children’s National shows promising long-term survival in children with aggressive brain tumors

A Phase I trial evaluated a novel multi-targeted T-cell therapy for children with deadly brain tumors, offering early evidence that the patient's own immune cells can reach and fight tumors while producing fewer severe side effects. The study suggests a safer and more effective approach for pediatric brain cancers.

SourceChildren's National Hospital·JournalNature Medicine·DateJun 30, 2026

Shorter strides can be an early warning sign of dementia in senior dogs, just as in people

A new study has found that changes in a senior dog's gait can be an early warning sign of dementia. The research tracked the stride length of 88 geriatric dogs over time, revealing a significant decrease in front leg stride length with worsening cognitive decline. This change was found to be more pronounced than age-related decline alone.

SourceFrontiers·JournalFrontiers in Veterinary Science·TypeExperimental study·DateJun 25, 2026

Can brain damage in neuromyelitis optica spectrum disorder keep progressing silently?

A recent international MRI study found evidence of ongoing neurodegeneration in NMOSD patients, even when they are clinically stable and not experiencing flare-ups. The research suggests that subtle cognitive decline may occur even in the absence of relapses, with brain atrophy rates being faster in NMOSD patients compared to healthy v...

SourceChiba University·JournalJournal of Neurology Neurosurgery & Psychiatry·DateJun 18, 2026

Brain-computer interface enables independent, accurate communication for man living with ALS

A brain-computer interface (BCI) system has been developed at the University of California - Davis Health, allowing a person with severe paralysis caused by amyotrophic lateral sclerosis (ALS) to communicate, work, and interact with the digital world without assistance. The BCI system has been tested in a 47-year-old man with ALS, who ...

SourceUniversity of California - Davis Health·JournalNature Medicine·DateJun 15, 2026

Texas Children’s Hospital and Baylor College of Medicine researcher awarded up to $17.25 million to join an international autism research collaborative

Baylor College of Medicine researcher Dr. Jimmy Holder and his team will join the ARIA IMPACT Network to accelerate clinical trial readiness and implementation for promising therapies on autism. The collaboration aims to better understand how autism develops and changes over time in children with profound autism.

Video game stroke rehab restores arm movement in chronic stroke survivors

A new study from Northwestern University developed a customized video game to help chronic stroke survivors regain lost arm function. After six weeks of therapy, participants showed significant improvement in arm function and daily activities, with scores improving up to 7.8 times that of the control group.

SourceNorthwestern University·JournalNeurorehabilitation and Neural Repair·TypeRandomized controlled/clinical trial·DateJun 9, 2026

Neuropixels Opto sheds new light on deepest regions of the brain

Researchers have developed a new device called Neuropixels Opto that can record and manipulate neuron activity in the brain. The device, published in Nature Methods, integrates electrophysiology and optogenetics to provide unprecedented insight into neural circuits and neurological conditions such as Alzheimer's disease and schizophrenia.

SourceUniversity College London·JournalNature Methods·TypeExperimental study·DateJun 1, 2026

Virtual-reality path integration for predicting risk of neurodegenerative diseases

Researchers found that impaired virtual reality path integration was closely tied to brain structure and biomarkers associated with neurodegeneration. This suggests that VR-based navigation errors may reveal hidden changes in the brain long before symptoms arise, making it a promising behavioral marker for preclinical Alzheimer's disease.

SourceFujita Health University·JournalAlzheimer s Research & Therapy·TypeObservational study·DateMay 27, 2026